BGIM
RMD icon

Boussard & Gavaudan Investment Management’s ResMed RMD Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4,859
Closed -$1.07M – 119
2023
Q2 		$1.07M Buy
+4,859
New +$1.08M 0.1% 78

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Boussard & Gavaudan Investment Management's RMD Position: Q3 2023 in Review

Boussard & Gavaudan Investment Management sold out of ResMed (RMD) in Q3 2023, closing a stake of 4,859 shares — an estimated $1.07M sold.

Boussard & Gavaudan Investment Management first reported a position in RMD in Q2 2023 and held it in 1 quarter. The position peaked at $1.07M in Q2 2023. 658 funds tracked by Wall St. Rank hold RMD as of Q3 2023.

  • Boussard & Gavaudan Investment Management reported no remaining ResMed position as of Q3 2023 after selling out during the quarter.
  • Boussard & Gavaudan Investment Management sold 4,859 ResMed shares in Q3 2023, an estimated $1.07M.
  • Boussard & Gavaudan Investment Management first reported a position in ResMed in Q2 2023 and held it in 1 quarter.
  • Boussard & Gavaudan Investment Management's ResMed position peaked at $1.07M in Q2 2023.
  • 658 funds tracked by Wall St. Rank held ResMed as of Q3 2023.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q3 2023, filed 13 Nov 2023.